Gene expression in ovarian carcinoma and correlation with prognostic factors and survival - A study of mRNA and miRNA profiling and differentiality
Metadata
Show metadataAppears in the following Collection
- Institutt for klinisk medisin [10950]
Abstract
No abstract.List of papers
Paper I: Elgaaen BV, Haug KBF, Wang J, Olstad OK, Fortunati D, Onsrud M, Staff AC, Sauer T, Gautvik KM. POLD2 and KSP37 (FGFBP2) correlate strongly with histology, stage and outcome in ovarian carcinomas. PLoS One. 2010;5(11):e13837. This is an open-access article distributed under the terms of the Creative Commons Attribution License. The published version of this paper is available at: https://doi.org/10.1371/journal.pone.0013837 |
Paper II: Elgaaen BV, Olstad OK, Sandvik L, Ødegaard E, Sauer T, Staff AC, Gautvik KM. ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival. PLoS One. 2012;7(9):e46317. This is an open-access article distributed under the terms of the Creative Commons Attribution License. The published version of this paper is available at: https://doi.org/10.1371/journal.pone.0046317 |
Paper III: Elgaaen BV, Olstad OK, Haug KBF, Brusletto B, Sandvik L, Staff AC, Gautvik KM, Davidson B. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker. Author version, published in: BMC Cancer 2014, 14:80. This is an Open Access article distributed under the terms of the Creative Commons Attribution License. The published version of this paper is available at: https://doi.org/10.1186/1471-2407-14-80 |